肿瘤抑制性三氮烯作用机制的研究。 - Suppr

Studies on the mechanism of action of the tumour inhibitory triazenes.

作者信息

Audette R C, Connors T A, Mandel H G, Merai K, Ross W C

出版信息

Biochem Pharmacol. 1973 Aug 1;22(15):1855-64. doi: 10.1016/0006-2952(73)90045-2.

DOI:10.1016/0006-2952(73)90045-2

PMID:4722457

Abstract

摘要

相似文献

Studies on the mechanism of action of the tumour inhibitory triazenes.

Biochem Pharmacol. 1973 Aug 1;22(15):1855-64. doi: 10.1016/0006-2952(73)90045-2.

Tumour inhibitory triazenes: structural requirements for an active metabolite.

Biochem Pharmacol. 1976 Feb 1;25(3):241-6. doi: 10.1016/0006-2952(76)90207-0.

Biologic characterization of the subcutaneously implanted Lewis lung tumor.

Cancer Chemother Rep 2. 1972 Nov;3(1):325-30.

Evaluation of 4-carbethoxy-5(3,3-dimethyl-1-triazeno)-2-phenylimidazole (NSC-166721) and 4-carbethoxy-5-(3,3-dimethyl-1-triazeno)-2-methylimidazole (NSC-166722) as potential antitumor agents.

Cancer Chemother Rep. 1973 Sep-Oct;57(3):263-8.

New platinum complexes with anti-tumour activity.

Chem Biol Interact. 1972 Nov;5(6):415-24. doi: 10.1016/0009-2797(72)90078-6.

Approaches to combination chemotherapy in rat, mouse, and hamster tumors.

Cancer Chemother Rep 2. 1974 Mar;4(1):99-108.

Chemotherapy of malignant melanoma.

Cancer. 1972 Dec;30(6):1604-15. doi: 10.1002/1097-0142(197212)30:6<1604::aid-cncr2820300629>3.0.co;2-5.

[Chemotherapy of malignant melanoma].

Schweiz Med Wochenschr. 1973 Oct 13;103(41):1426-8.

Tumor inhibitory triazenes. 3. Dealkylation within an homologous series and its relation to antitumor activity.

J Med Chem. 1984 Jul;27(7):870-4. doi: 10.1021/jm00373a011.

Cytotoxic sulphonamides designed for selective deposition in malignant tissue.

Eur J Cancer (1965). 1975 Nov;11(11):787-93. doi: 10.1016/0014-2964(75)90172-3.

引用本文的文献

Combination chemotherapy.

Proc R Soc Med. 1974 Jun;67(6 Pt 1):434-6. doi: 10.1177/00359157740676P103.

Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277.

Br J Cancer. 1993 Feb;67(2):362-8. doi: 10.1038/bjc.1993.66.

Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.

Cancer Chemother Pharmacol. 1984;13(2):139-41. doi: 10.1007/BF00257132.

The binding of 14C labelled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) to macromolecules of sensitive and resistant tumours.

Br J Cancer. 1974 Nov;30(5):477-80. doi: 10.1038/bjc.1974.224.

[Carcinogenic activity of 13 aryldialkyl triazenes in BD-rats (author's transl)].

Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974;81(3-4):285-310. doi: 10.1007/BF00305031.

N-methyl antitumour agents. A distinct class of anticancer drugs?

Cancer Chemother Pharmacol. 1987;19(2):91-102. doi: 10.1007/BF00254559.

Effects of an inducer and an inhibitor of hepatic metabolism on the antitumor action of dimethyltriazenes.

Cancer Chemother Pharmacol. 1988;21(3):241-5. doi: 10.1007/BF00262778.

Metabolism and pharmacokinetics of p-(3,3-dimethyl-1-triazeno) benzoic acid in M5076 sarcoma-bearing mice.

Cancer Chemother Pharmacol. 1989;24(6):354-8. doi: 10.1007/BF00257441.

DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivity.

Br J Cancer. 1988 Aug;58(2):171-5. doi: 10.1038/bjc.1988.186.

Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.

Cancer Chemother Pharmacol. 1991;27(6):423-8. doi: 10.1007/BF00685155.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Studies on the mechanism of action of the tumour inhibitory triazenes.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献